Lördag 24 Maj | 15:56:24 Europe / Stockholm
Svenska | English

H100 Group

Bifogade filer

Prenumeration

Kalender

Est. tid*
2025-11-28 08:30 Kvartalsrapport 2026-Q2
2025-09-11 N/A Årsstämma
2025-06-11 17:30 Bokslutskommuniké 2025
2024-12-02 - Kvartalsrapport 2025-Q2
2024-09-20 - Årsstämma
2024-08-13 - X-dag ordinarie utdelning H100 0.00 SEK
2024-06-11 - Bokslutskommuniké 2024
2024-01-30 - Extra Bolagsstämma 2024
2023-11-30 - Kvartalsrapport 2024-Q2
2023-09-14 - X-dag ordinarie utdelning H100 0.00 SEK
2023-09-13 - Årsstämma
2023-07-31 - Bokslutskommuniké 2023
2023-07-20 - X-dag ordinarie utdelning H100 0.00 SEK
2023-06-30 - Bokslutskommuniké 2023
2022-11-30 - Kvartalsrapport 2023-Q2
2022-07-12 - X-dag ordinarie utdelning H100 0.00 SEK
2022-07-11 - Årsstämma
2022-05-16 - Bokslutskommuniké 2022
2021-11-29 - Kvartalsrapport 2022-Q2
2021-07-07 - Årsstämma
2021-06-30 - X-dag ordinarie utdelning H100 0.00 SEK
2021-05-31 - Bokslutskommuniké 2021
2021-01-20 - Extra Bolagsstämma 2021
2020-11-23 - Kvartalsrapport 2021-Q2
2020-06-30 - X-dag ordinarie utdelning H100 0.00 SEK
2020-06-29 - Årsstämma
2020-05-22 - Bokslutskommuniké 2020

Beskrivning

LandSverige
ListaNordic SME Sweden
SektorFinans
IndustriInvesteringar
H100 Group är ett hälsoteknikbolag verksamt inom hälso- och livslängdsbranschen. Bolagets affärsidé är att stödja leverantörer av hälso- och livsstilstjänster genom AI-driven automation, digitala tillväxtverktyg och integrerade plattformslösningar. Bolaget följer en tillväxtstrategi fokuserad på att bygga ett ekosystem där AI-integration ökar effektiviteten och utökar tjänsteutbudet. H100 Group har sitt huvudkontor i Stockholm.
H100 Group enter into Letter of Intent to establish a convertible loan facility up to SEK 10 million
2025-05-23 08:52:00

Stockholm, 23 May 2025— H100 Group (NGM: H100) has today entered into an LOI to establish a convertible loan facility with an undisclosed financial investor. The intended use for the proceeds is general corporate purposes and further expanding H100 Bitcoin treasury.

The loan is intended to be up to SEK 10 million, have 3-year duration and be convertible for the investor at any time at a conversion price of SEK 1.3 per share. If the H100 share trades at WVAP above 33% above the conversion price for more than an accumulated 60 days, H100 shall have the right to demand conversion of the loan.

The entering into of the final loan agreement is amongst other conditional on negotiation of final agreement, board approval in H100 and other approvals as may be.

Contact

Sander Andersen, CEO H100 Group AB
E-mail: sander.andersen@h100.group

About H100 Group

H100 Group AB is a health technology company operating in the health and longevity industry. The company’s business idea is to support providers of health and lifestyle services through AI-powered automation, digital growth tools, and integrated platform solutions, with the goal of helping people live healthy lives to 100 and beyond.
H100 follows a clear growth strategy focused on building a seamless ecosystem where AI integration enhances efficiency and expands service offerings. Growth is further accelerated through strategic acquisitions of key players within its ecosystem, aiming to consolidate and scale the business.
The company is listed on NGM Nordic SME. For more information, visit www.h100.group.

Attachments

H100 Group enter into Letter of Intent to establish a convertible loan facility up to SEK 10 million

Källa MFN
Enter your email address and you will get a mail for verification you subscription to content on this page and filter


Select the time zone location for site wide time

Europe
London
Oslo
Stockholm
Helsinki

America
New York / Eastern
Chicago / Central
Los Angeles / Western

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden